Hyperkalemia is a serious condition that commonly affects those with heart failure. This 3D mechanism of action video will explore how serum potassium levels rise due to disruptions in the renin-angiotensin-aldosterone system and the mechanisms of novel potassium binders to combat this condition.
Balancing RAASi Therapy and Potassium: Understanding How it Works
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Related
Recommended
Details
Related
Overview
Hyperkalemia is a serious condition that commonly affects those with heart failure. This 3D mechanism of action video will explore how serum potassium levels rise due to disruptions in the renin-angiotensin-aldosterone system and the mechanisms of novel potassium binders to combat this condition.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Medical Industry Feature
Digital Therapeutics Clinical Trials: From Design to Data Interpretation
<p>Digital Therapeutics Clinical Trials: From Design to Data Interpretation </p>
Medical Industry Feature
Engaging Patients and Caregivers About Digital Therapeutics
<p>Engaging Patients and Caregivers About Digital Therapeutics</p>
CME/CE Broadcast Replay
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
1.00 credits
<p>Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease</p>
CME/CE
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
0.50 credits
<p>IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement</p>
CME/CE
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
0.50 credits
<p>New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure</p>
MinuteCE®
HF Management for Patients with Comorbid Conditions
0.75 credits
<p>HF Management for Patients with Comorbid Conditions</p>
CME/CE
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
0.50 credits
<p><span data-contrast="auto" xml:lang="EN-US">Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow</span><span data-ccp-props='{"201341983":0,"335559739":0,"335559740":240}'> </span></p>
CME/CE
Personalizing Care Within the RCC Treatment Paradigm
1.00 credits
<p>Personalizing Care Within the RCC Treatment Paradigm</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?